腾讯微保与国药控股、壹树医疗达成战略合作 探索商保与大健康产业融合新模式
据《中国证券报》报道,腾讯微保联合国药控股(01099.HK)、上海壹树医疗科技有限公司宣布签署三方战略合作协议,未来将在城市级社商融合普惠型商业保险项目、药品福利项目、商业保险项目以及患者服务项目上进行深度合作。
据了解,合作三方将从城市普惠险、药品福利项目、商业保险合作等三个维度进行探索与合作。腾讯微保作为互联网保险行业的领导者,通过积极发挥「连接器」功能,与险企一起参与产品设计,在「医药分家」的背景下,持续扩大用户用药的可及性,连接支付方、医疗服务提供方、药品供应方,围绕用户需求形成闭环式互联网解决方案。
另一方面,国药控股依托其覆盖全国的线下药房场景,为用户提供「互联网医疗平台+药品配送+药事服务」等全流程的医药服务;壹数医疗以医药学和科技为核心,依托药物经济学目录设计、临床路径用药审核、线上患者管理平台等优势,为用户提供「用药咨询、患者随访」等健康管理增值服务。(ad/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.